NCT02765841View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

December 31, 2019

Conditions
Homozygous Familial Hypercholesterolemia
Interventions
DRUG

Lomitapide

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT02765841 - Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy | Biotech Hunter | Biotech Hunter